DoW Joint Warfighter Medical, Military Medical Research and Development Award
About
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas. Distinctive Features: To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding. An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional.
The DoW Joint Warfighter Medical, Military Medical Research and Development Award (MMRDA) is designed for researchers and organizations seeking to advance military medical innovation and improve healthcare outcomes for Service Members and Military Health System beneficiaries. This grant supports the logical continuation of previously Department of War-funded research and development efforts that align with the Joint Warfighter Medical Research Program (JWMRP) priorities. Funding encompasses a comprehensive range of research activities, including late-stage preclinical studies, technology development, technology demonstration, translational research, and clinical investigations. Researchers should apply if their work addresses high-priority medical requirements identified in the FY26 JWMRP focus areas. A specialized Clinical Research and Clinical Trial Option (MMRDA-CRCTO) is available for applicants conducting human subjects research, working with human biological samples, or analyzing human datasets. This award is particularly valuable for organizations with existing DoD/DOW core funding or Congressional Special Interest funding who are positioned to accelerate promising medical solutions from development through clinical validation.
Funding Facts
● Applications openDeadline
November 16, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by project scope
Deadline
2026-11-16
Grant Type
federal
Application Cycle
Annual (FY2026 cycle with November 16, 2026 deadline)
Best For
Organizations with previous DoD/DoW funding conducting medical research and development aligned with Joint Warfighter Medical Research Program priorities
Frequently Asked Questions
Who is eligible for DoW Joint Warfighter Medical, Military Medical Research and Development Award?
Applicants and offerors must have previously received Department of War (DoW) or Department of Defense (DoD) core funding or Congressional Special Interest funding to be eligible for JWMRP MMRDA support. Organizations with established DoW-funded research programs relevant to FY26 JWMRP focus areas are prioritized. For specific eligibility requirements and institutional qualifications, consult the official DoW JWMRP announcement and guidelines.
How much funding does DoW Joint Warfighter Medical, Military Medical Research and Development Award provide?
Specific funding amounts vary by research project scope and category. Award amounts are not specified in the current program summary. Contact the DoW JWMRP program office or review the official solicitation for detailed information about funding ranges and budget expectations for your research category.
How do I apply for DoW Joint Warfighter Medical, Military Medical Research and Development Award?
Submit applications through the official Department of War JWMRP submission portal by the November 16, 2026 deadline. Applicants should clearly demonstrate how their project aligns with FY26 JWMRP focus areas and builds on previous DoW-funded work. If your research involves human subjects, samples, or datasets, select the MMRDA-CRCTO option and submit required additional documentation. Visit the official DoW JWMRP website for complete submission instructions, required forms, and technical assistance.
What can DoW Joint Warfighter Medical, Military Medical Research and Development Award funding be used for?
MMRDA funding supports late-stage preclinical studies, late-stage technology development, technology demonstration, translational research, and clinical research projects. The specialized MMRDA-CRCTO option funds clinical research, observational studies, all phases of clinical trials, interventional studies, and correlative studies supporting pharmaceutical, biologic, medical device, and technology development. All projects must be relevant to at least one FY26 JWMRP focus area and serve the needs of Service Members and Military Health System beneficiaries.
Last updated: July 5, 2026